Working… Menu

iCAT for Recurrent/Refractory/HR Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01853345
Recruitment Status : Completed
First Posted : May 15, 2013
Last Update Posted : February 10, 2015
Information provided by (Responsible Party):
Katherine Janeway, MD, Dana-Farber Cancer Institute